Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
Youssef Dgachi, Hélène Martin, R.S. Malek, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2018) Vol. 34, Iss. 1, pp. 163-170
Open Access | Times Cited: 19

Showing 19 citing articles:

Novel Approaches for the Treatment of Alzheimer’s and Parkinson’s Disease
Michiel Van Bulck, Ana Sierra‐Magro, Jesús Alarcón-Gil, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 719-719
Open Access | Times Cited: 154
Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases
Vanessa Silva Gontijo, Flávia P. Dias Viegas, Cindy Juliet Cristancho Ortiz, et al.
Current Neuropharmacology (2019) Vol. 18, Iss. 5, pp. 348-407
Open Access | Times Cited: 91
Merged Tacrine-Based, Multitarget-Directed Acetylcholinesterase Inhibitors 2015–Present: Synthesis and Biological Activity
Todd J. Eckroat, Danielle L. Manross, Seth C. Cowan
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5965-5965
Open Access | Times Cited: 39
Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects
Július Brtko
Archiv der Pharmazie (2022) Vol. 355, Iss. 10
Closed Access | Times Cited: 25
Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments
Óscar M. Bautista‐Aguilera, Lhassane Ismaïli, Isabel Iriepa, et al.
The Chemical Record (2020) Vol. 21, Iss. 1, pp. 162-174
Open Access | Times Cited: 26
Critical evaluation of current Alzheimer’s drug discovery (2018–19) & futuristic Alzheimer drug model approach
Atukuri Dorababu
Bioorganic Chemistry (2019) Vol. 93, pp. 103299-103299
Closed Access | Times Cited: 25
Design, synthesis and biological assessment of acridine derivatives containing 1,3,4-thiadiazole moiety as novel selective acetylcholinesterase inhibitors
Safa Lotfi, Talat Rahmani, Maryam Hatami, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104457-104457
Closed Access | Times Cited: 23
Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors
Maja Przybyłowska, Krystyna Dzierzbicka, Szymon Kowalski, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 8, pp. 1323-1344
Open Access | Times Cited: 22
Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties
Irène Pachón-Angona, Paul J. Bernard, Alexey Simakov, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 121-121
Open Access | Times Cited: 2
Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment
Imen Dakhlaoui, Paul J. Bernard, Diana Pietrzak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9742-9742
Open Access | Times Cited: 6
Alzheimer’s disease: Key developments support promising perspectives for therapy
Jacopo Meldolesi
Pharmacological Research (2019) Vol. 146, pp. 104316-104316
Closed Access | Times Cited: 18
Synthesis and biological assessment of new pyrimidopyrimidines as inhibitors of breast cancer resistance protein (ABCG2)
Imen Dakhlaoui, Sahel Vahdati, Emna Maalej, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105326-105326
Open Access | Times Cited: 15
Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation
R.S. Malek, Alexey Simakov, Audrey Davis, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 71-71
Open Access | Times Cited: 9
Synthesis, biological evaluation, and computational studies of novel fused six-membered O-containing heterocycles as potential acetylcholinesterase inhibitors
Yaghoub Pourshojaei, Ardavan Abiri, Razieh Eskandari, et al.
Computational Biology and Chemistry (2019) Vol. 80, pp. 249-258
Closed Access | Times Cited: 14
Diverse therapeutic potential of 3-hydroxy-4-pyranones and related compounds as kojic acid analogs
Saeed Emami, Reza Ahmadi, Hamideh Ahadi, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 11, pp. 1842-1861
Closed Access | Times Cited: 7
Recent Modifications of Anti-dementia Agents Focusing on Tacrine and/or Donepezil Analogs
Lamia W. Mohamed, Khaled O. Mohamed, Hadeer S. Sayed, et al.
Medicinal Chemistry (2022) Vol. 19, Iss. 4, pp. 311-324
Closed Access | Times Cited: 5
Synthesis and Biological Assessment of PyrimidoTacrines as Promising Agents for Alzheimer's Disease Therapy
Imen Dakhlaoui, Emna Maalej, Hélène Martin, et al.
ChemistrySelect (2021) Vol. 6, Iss. 37, pp. 9975-9980
Closed Access | Times Cited: 3
Structural Fractal Analysis of the Active Site of Acetylcholinesterase in Complexes with Huperzine A, Galantamine, and Donepezil
V. Yu. Grigorev, Alexander N. Rasdolsky, L. D. Grigoreva, et al.
Molecular Informatics (2021) Vol. 40, Iss. 11
Closed Access | Times Cited: 2
Multi-functional Ligands and Molecular Hybridization: Conceptual Aspects and Application in the Innovative Design of Drug Candidate Prototypes for Neurodegenerative Diseases
Matheus de Freitas Silva, Flávia Pereira Dias Viegas, Vanessa Silva Gontijo, et al.
Frontiers in clinical drug research. CNS and neurological disorders (2023), pp. 1-157
Open Access
Page 1

Scroll to top